当前位置: X-MOL 学术J. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27–Controlled Differentiation to Become TCF1− Terminal Effectors during the Progression of Type 1 Diabetes
The Journal of Immunology ( IF 4.4 ) Pub Date : 2021-10-15 , DOI: 10.4049/jimmunol.2100362
Ashley E. Ciecko 1 , David M. Schauder 1, 2 , Bardees Foda 3, 4, 5 , Galina Petrova 3 , Moujtaba Y. Kasmani 1, 2 , Robert Burns 2 , Chien-Wei Lin 6 , William R. Drobyski 1, 7 , Weiguo Cui 1, 2 , Yi-Guang Chen 1, 3, 4
Affiliation  

In type 1 diabetes (T1D) autoreactive CD8 T cells infiltrate pancreatic islets and destroy insulin-producing β cells. Progression to T1D onset is a chronic process, which suggests that the effector activity of β-cell autoreactive CD8 T cells needs to be maintained throughout the course of disease development. The mechanism that sustains diabetogenic CD8 T cell effectors during the course of T1D progression has not been completely defined. Here we used single-cell RNA sequencing to gain further insight into the phenotypic complexity of islet-infiltrating CD8 T cells in NOD mice. We identified two functionally distinct subsets of activated CD8 T cells, CD44highTCF1+CXCR6 and CD44highTCF1CXCR6+, in islets of prediabetic NOD mice. Compared with CD44highTCF1+CXCR6 CD8 T cells, the CD44highTCF1CXCR6+ subset expressed higher levels of inhibitory and cytotoxic molecules and was more prone to apoptosis. Adoptive cell transfer experiments revealed that CD44highTCF1+CXCR6 CD8 T cells, through continuous generation of the CD44highTCF1CXCR6+ subset, were more capable than the latter population to promote insulitis and the development of T1D. We further showed that direct IL-27 signaling in CD8 T cells promoted the generation of terminal effectors from the CD44highTCF1+CXCR6 population. These results indicate that islet CD44highTCF1+CXCR6 CD8 T cells are a progenitor-like subset with self-renewing capacity, and, under an IL-27–controlled mechanism, they differentiate into the CD44highTCF1CXCR6+ terminal effector population. Our study provides new insight into the sustainability of the CD8 T cell response in the pathogenesis of T1D.



中文翻译:

自我更新胰岛 TCF1+ CD8 T 细胞在 1 型糖尿病进展期间经历 IL-27 控制的分化成为 TCF1− 末端效应器

在 1 型糖尿病 (T1D) 中,自身反应性 CD8 T 细胞浸润胰岛并破坏产生胰岛素的 β 细胞。进展为 T1D 发病是一个慢性过程,这表明 β 细胞自身反应性 CD8 T 细胞的效应活性需要在整个疾病发展过程中保持。在 T1D 进展过程中维持致糖尿病 CD8 T 细胞效应器的机制尚未完全确定。在这里,我们使用单细胞 RNA 测序来进一步了解 NOD 小鼠胰岛浸润 CD8 T 细胞的表型复杂性。我们鉴定了两个功能不同的活化 CD8 T 细胞亚群,CD44TCF1 + CXCR6 -和 CD44TCF1 - CXCR6 +,在糖尿病前期 NOD 小鼠的胰岛中。与 CD44TCF1 + CXCR6 - CD8 T 细胞相比,CD44TCF1 - CXCR6 +子集表达更高水平的抑制性和细胞毒性分子,更容易发生细胞凋亡。过继细胞转移实验表明,CD44TCF1 + CXCR6 CD8 T 细胞,通过持续产生 CD44TCF1 CXCR6 +子集,比后者更有能力促进胰岛炎和 T1D 的发展。我们进一步表明,CD8 T 细胞中的直接 IL-27 信号传导促进了来自 CD44TCF1 + CXCR6 -群体的末端效应子的产生。这些结果表明胰岛 CD44TCF1 + CXCR6 - CD8 T 细胞是具有自我更新能力的祖细胞亚群,并且在 IL-27 控制的机制下,它们分化为 CD44TCF1 - CXCR6 +末端效应细胞群. 我们的研究为 CD8 T 细胞反应在 T1D 发病机制中的可持续性提供了新的见解。

更新日期:2021-10-06
down
wechat
bug